ID

26017

Descrizione

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00437294

collegamento

https://clinicaltrials.gov/show/NCT00437294

Keywords

versioni (2)
  1. 02/10/17 02/10/17 -
  2. 04/10/17 04/10/17 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

4 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT00437294

Inglese

Eligibility Breast Cancer NCT00437294

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
have been diagnosed with metastatic or recurrent breast cancer.
Descrizione

Secondary malignant neoplasm of female breast | Breast cancer recurrent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0346993
UMLS CUI [2]
C0278493
have been previously treated with both an anthracycline and a taxane.
Descrizione

Anthracyclines | Taxane

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0282564
UMLS CUI [2]
C0215136
have not received more than two prior chemotherapy treatment programs.
Descrizione

Chemotherapy Regimen Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
have stopped any antitumoral hormonal treatment before you enroll in this study.
Descrizione

Antineoplastic Hormonal Agents Discontinued

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0282559
UMLS CUI [1,2]
C1444662
have a negative pregnancy blood test if menstruating or capable of becoming pregnant. you must use an approved birth control method during the study and for 3 months after stopping study treatment.
Descrizione

Menstruation Serum pregnancy test negative | Childbearing Potential Serum pregnancy test negative | Menstruation Contraceptive methods | Childbearing Potential Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0025344
UMLS CUI [1,2]
C0430061
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0430061
UMLS CUI [3,1]
C0025344
UMLS CUI [3,2]
C0700589
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0700589
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
cannot follow the study procedures (for example, you can not swallow tablets)
Descrizione

Protocol Compliance Unable | Lacking Able to swallow Tablets

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0332268
UMLS CUI [2,2]
C2712086
UMLS CUI [2,3]
C0039225
are receiving another treatment for your cancer.
Descrizione

Cancer treatment

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0920425
have received another experimental drug in the last 4 weeks.
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
have had serious heart disease within last 6 months.
Descrizione

Heart Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018799
are pregnant or breast-feeding.
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Ritorna all'inizio della pagina

Similar models

Eligibility Breast Cancer NCT00437294

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Secondary malignant neoplasm of female breast | Breast cancer recurrent
Item
have been diagnosed with metastatic or recurrent breast cancer.
boolean
C0346993 (UMLS CUI [1])
C0278493 (UMLS CUI [2])
Anthracyclines | Taxane
Item
have been previously treated with both an anthracycline and a taxane.
boolean
C0282564 (UMLS CUI [1])
C0215136 (UMLS CUI [2])
Chemotherapy Regimen Quantity
Item
have not received more than two prior chemotherapy treatment programs.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Antineoplastic Hormonal Agents Discontinued
Item
have stopped any antitumoral hormonal treatment before you enroll in this study.
boolean
C0282559 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
Menstruation Serum pregnancy test negative | Childbearing Potential Serum pregnancy test negative | Menstruation Contraceptive methods | Childbearing Potential Contraceptive methods
Item
have a negative pregnancy blood test if menstruating or capable of becoming pregnant. you must use an approved birth control method during the study and for 3 months after stopping study treatment.
boolean
C0025344 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0430061 (UMLS CUI [2,2])
C0025344 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
Item Group
C0680251 (UMLS CUI)
Protocol Compliance Unable | Lacking Able to swallow Tablets
Item
cannot follow the study procedures (for example, you can not swallow tablets)
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0332268 (UMLS CUI [2,1])
C2712086 (UMLS CUI [2,2])
C0039225 (UMLS CUI [2,3])
Cancer treatment
Item
are receiving another treatment for your cancer.
boolean
C0920425 (UMLS CUI [1])
Investigational New Drugs
Item
have received another experimental drug in the last 4 weeks.
boolean
C0013230 (UMLS CUI [1])
Heart Disease
Item
have had serious heart disease within last 6 months.
boolean
C0018799 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
are pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial